Experts agree that addiction is a disease, yet the disease model doesn't capture addiction's harmful effects on others.

We need a new paradigm for addiction that puts psychology first and recognizes its heterogeneity. Only then will we see that ...

Despite fewer new addiction cases worldwide, a sweeping analysis finds drug-related deaths surging, exposing critical failures in global harm-reduction and recovery systems. Study: The evolving burden ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...